Vera Therapeutics (VERA) had the highest return between January 8, 2024 and January 30, 2024 by a mid-cap US stock, returning 120.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/8/2024 - 1/30/2024 | 120.93% |
Trump Media & Technology (DJT) | 1/8/2024 - 1/30/2024 | 119.77% |
Sezzle Inc Common Stock (SEZL) | 1/8/2024 - 1/30/2024 | 110.6% |
Dave (DAVE) | 1/8/2024 - 1/30/2024 | 108.59% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 1/8/2024 - 1/30/2024 | 53.98% |
Oscar Health (OSCR) | 1/8/2024 - 1/30/2024 | 44.42% |
PureCycle Technologies (PCTTW) | 1/8/2024 - 1/30/2024 | 44.4% |
Advantage Solutions (ADVWW) | 1/8/2024 - 1/30/2024 | 43.01% |
Rumble (RUM) | 1/8/2024 - 1/30/2024 | 41.63% |
Appfolio (APPF) | 1/8/2024 - 1/30/2024 | 36.53% |
Vericel Corp Ord (VCEL) | 1/8/2024 - 1/30/2024 | 36.44% |
Rush Street Interactive (RSI) | 1/8/2024 - 1/30/2024 | 35.84% |
GeneDx (WGS) | 1/8/2024 - 1/30/2024 | 33.69% |
Viking Therapeutics (VKTX) | 1/8/2024 - 1/30/2024 | 30.59% |
Sanmina (SANM) | 1/8/2024 - 1/30/2024 | 29.82% |
Grupo Financiero Galicia SA ADR (GGAL) | 1/8/2024 - 1/30/2024 | 29.18% |
Intapp (INTA) | 1/8/2024 - 1/30/2024 | 27.49% |
Banco Macro SA B ADR (BMA) | 1/8/2024 - 1/30/2024 | 27.38% |
Soleno Therapeutics (SLNO) | 1/8/2024 - 1/30/2024 | 26.44% |
Apogee Therapeutics, Inc Common Stock (APGE) | 1/8/2024 - 1/30/2024 | 26.1% |
CG Oncology, Inc Common stock (CGON) | 1/8/2024 - 1/30/2024 | 25.86% |
PBF Energy (PBF) | 1/8/2024 - 1/30/2024 | 25.71% |
Merus (MRUS) | 1/8/2024 - 1/30/2024 | 25.64% |
Gitlab (GTLB) | 1/8/2024 - 1/30/2024 | 25.58% |
Bancorp (TBBK) | 1/8/2024 - 1/30/2024 | 25.14% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
